- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Hercules Technology Growth Capital, Inc. (NASDAQ:HTGC), the premier specialty finance company providing venture debt and equity to venture capital and private equity backed technology and life science companies at all stages of development, announced that two senior members of its team have been invited to present at the Emerging Technology Investment Forum Jan. 23-24 in San Jose. Kathy Conte, managing director of life sciences, and Sam Bhaumik, senior managing director and group head of technology, will be presenting at the event.
The event will provide a forum for entrepreneurs and early-stage small businesses in the life sciences and technology industries interested in securing venture capital funding to learn about best practice strategies and approaches from venture capital and angel investment firms like Hercules.
Conte will be participating in a panel discussion on Jan. 24 from 9-10:30 a.m. PT focused on opportunities and challenges for start-up companies in the life sciences industry. Bhaumik will participate in a similar panel discussion from 1:30-3 p.m. PT on Jan. 24 focusing on the technology industry. Both Bhaumik and Conte will highlight the competitive advantages of venture debt as an alternative source of growth capital for start-up companies in these sectors.
The forum - sponsored by the International Association of Nanotechnology - anticipates 45-50 presenting companies in major emerging technology fields, including clean tech, nanotech, biotech, aerospace, medical device and instruments as well as pharmaceuticals.
About Hercules Technology Growth Capital, Inc.
Hercules Technology Growth Capital, Inc. is a NASDAQ traded specialty finance company providing debt and equity growth capital to technology and life science companies at all stages of development. Founded in December 2003, the company primarily finances privately held companies backed by leading venture capital and private equity firms. Hercules invests in a broad range of ventures active in technology and life science industries and offers a full suite of growth capital products up and down the capital structure. The company is headquartered in Palo Alto, Calif. and has additional offices in the Boston, Boulder, San Diego and Chicago areas. Providing capital to publicly-traded or privately-held companies backed by leading venture capital and private equity firms involves a high degree of credit risk and may result in potential losses of capital. For more information, please visit www.HTGC.com.
Companies interested in learning more about financing opportunities should contact or call 650.289.3060.
The statements contained in this release that are not purely historical are forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to uncertainties and other factors that could cause actual results to differ materially from those expressed in the forward-looking statements including, without limitation, the risks, uncertainties and other factors we identify from time to time in our filings with the Securities and Exchange Commission. Although we believe that the assumptions on which these forward-looking statements are reasonable, any of those assumptions could prove to be inaccurate and, as a result, the forward-looking statements based on those assumptions also could be incorrect. You should not place undue reliance on these forward-looking statements. The forward-looking statements contained in this release are made as of the date hereof, and Hercules assumes no obligation to update the forward-looking statements for subsequent events.
For more information, please click here
Hercules Technology Growth Capital, Inc.
Main, 650.289.3060 HT-HN
Sally Borg, 650.289.3066
Copyright © Business Wire 2008If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
BESSTECH Announces $250K Investment from Eastern New York Angels : Funding will accelerate commercialization of BESSTECH’s innovative lithium-ion battery electrode technology and enable hiring of key personnel May 13th, 2015
Harris & Harris Group Sponsors NYC American Heart Association's Health Sciences Innovation Investment Forum: Co-founder of Harris & Harris Group Portfolio Company TARA Biosystems to Speak About the Value of Tissue Engineering Technology April 21st, 2015
Long Island Capital Alliance Announces Participants for Brookhaven National Laboratory Technology Transfer Capital Forum on May 8: Keynote Speaker Dr. Doon Gibbs, Director of Brookhaven National Laboratory April 16th, 2015
Haydale Named Lead Sponsor for Cambridge Graphene Festival May 22nd, 2015
Directa Plus in Barcelona to present the innovative project GEnIuS for oil spills clean-up activities: The company has created a graphene-based product for the remediation of water contaminated by oil and hydrocarbons May 21st, 2015